Immune Checkpoint in Glioblastoma: Promising and Challenging

Glioblastoma (GBM) is a severe malignant brain cancer with poor overall survival. Conventional intervention remains dismal to prevent recurrence and deterioration of GBM cell. Recent years have witnessed exciting breakthroughs in novel immune strategies, especially checkpoint inhibitors, some of whi...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Front Pharmacol
Main Authors: Huang, Jing, Liu, Fangkun, Liu, Zhixiong, Tang, Hui, Wu, Haishan, Gong, Qianni, Chen, Jindong
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2017
Teme:
Pharmacology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5422441/
https://ncbi.nlm.nih.gov/pubmed/28536525
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2017.00242
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki